Dana-Farber Cancer Institute /ID# 277732

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer — Recruiting now